-
1.METHOD TO USE GENE EXPRESSION TO DETERMINE LIKELIHOOD OF CLINICAL OUTCOME OF RENAL CANCER 有权
标题翻译: 使用基因表达测定肾癌临床观察结果的方法公开(公告)号:US20110171633A1
公开(公告)日:2011-07-14
申请号:US12987023
申请日:2011-01-07
申请人: Wayne Cowens , Steven Shak , Audrey Goddard , Dejan Knezevic , Joffre B. Baker , Michael C. Kiefer , Tara Maddala , Frederick L. Baehner
发明人: Wayne Cowens , Steven Shak , Audrey Goddard , Dejan Knezevic , Joffre B. Baker , Michael C. Kiefer , Tara Maddala , Frederick L. Baehner
CPC分类号: C12Q1/6886 , C12Q2600/112 , C12Q2600/118 , C12Q2600/158 , G01N33/57438 , G06F19/00 , G06F19/10 , G06N7/005 , G16H50/20
摘要: The present disclosure provides gene and gene sets, the expression of which is important in the classification and/or prognosis of cancer, in particular of renal cell carcinoma.
摘要翻译: 本公开提供了基因和基因组,其表达在癌症,特别是肾细胞癌的分类和/或预后中是重要的。
-
2.Method to use gene expression to determine likelihood of clinical outcome of renal cancer 有权
标题翻译: 使用基因表达来确定肾癌临床结局的可能性的方法公开(公告)号:US09551034B2
公开(公告)日:2017-01-24
申请号:US12987023
申请日:2011-01-07
申请人: Wayne Cowens , Steven Shak , Audrey Goddard , Dejan Knezevic , Joffre Baker , Michael C. Kiefer , Tara Maddala , Frederick L. Baehner
发明人: Wayne Cowens , Steven Shak , Audrey Goddard , Dejan Knezevic , Joffre Baker , Michael C. Kiefer , Tara Maddala , Frederick L. Baehner
IPC分类号: C12Q1/68 , G01N33/574
CPC分类号: C12Q1/6886 , C12Q2600/112 , C12Q2600/118 , C12Q2600/158 , G01N33/57438 , G06F19/00 , G06F19/10 , G06N7/005 , G16H50/20
摘要: The present disclosure provides gene and gene sets, the expression of which is important in the classification and/or prognosis of cancer, in particular of renal cell carcinoma.
摘要翻译: 本公开提供了基因和基因组,其表达在癌症,特别是肾细胞癌的分类和/或预后中是重要的。
-
3.METHOD FOR USING GENE EXPRESSION TO DETERMINE PROGNOSIS OF PROSTATE CANCER 审中-公开
标题翻译: 使用基因表达来确定前列腺癌预后的方法公开(公告)号:US20120028264A1
公开(公告)日:2012-02-02
申请号:US13190391
申请日:2011-07-25
申请人: Steven Shak , Frederick L. Baehner , Tara Maddala , Mark Lee , Robert J. Pelham , Wayne Cowens , Diana Cherbavaz , Michael C. Kiefer , Michael Crager , Audrey Goddard , Joffre B. Baker
发明人: Steven Shak , Frederick L. Baehner , Tara Maddala , Mark Lee , Robert J. Pelham , Wayne Cowens , Diana Cherbavaz , Michael C. Kiefer , Michael Crager , Audrey Goddard , Joffre B. Baker
IPC分类号: C12Q1/68
摘要: Molecular assays that involve measurement of expression levels of prognostic biomarkers, or co-expressed biomarkers, from a biological sample obtained from a prostate cancer patient, and analysis of the measured expression levels to provide information concerning the likely prognosis for said patient, and likelihood that said patient will have a recurrence of prostate cancer, or to classify the tumor by likelihood of clinical outcome or TMPRSS2 fusion status, are provided herein.
摘要翻译: 涉及从前列腺癌患者获得的生物样品中测量预后生物标志物或共表达生物标志物的表达水平的分子测定,以及测量的表达水平的分析以提供关于所述患者的可能预后的信息,以及可能性 所述患者将具有前列腺癌的复发,或通过临床结果或TMPRSS2融合状态的可能性来分类肿瘤。
-
4.Method for Determining the Likelihood of Response to HER2 Inhibitors 审中-公开
标题翻译: 确定对HER2抑制剂的响应的可能性的方法公开(公告)号:US20100151463A1
公开(公告)日:2010-06-17
申请号:US12554783
申请日:2009-09-04
申请人: Frederick L. Baehner , Drew Watson , Tara Maddala , Steve Shak , Robert Gray , Joseph Sparano
发明人: Frederick L. Baehner , Drew Watson , Tara Maddala , Steve Shak , Robert Gray , Joseph Sparano
IPC分类号: C12Q1/68
CPC分类号: C12Q1/6886 , C12Q2600/106 , C12Q2600/112 , C12Q2600/158
摘要: The present disclosure provides methods for determining the HER2 Status of a cancer tumor sample.
摘要翻译: 本公开提供了确定癌症肿瘤样品的HER2状态的方法。
-
-
-